CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $132,000 | -37.1% | 2,500 | -19.4% | 0.00% | 0.0% |
| Q4 2017 | $210,000 | -50.9% | 3,100 | -40.4% | 0.00% | -50.0% |
| Q3 2017 | $428,000 | -18.3% | 5,200 | -7.1% | 0.00% | 0.0% |
| Q2 2017 | $524,000 | -41.5% | 5,600 | -60.2% | 0.00% | -50.0% |
| Q1 2017 | $896,000 | +7.8% | 14,079 | +55.8% | 0.00% | 0.0% |
| Q3 2015 | $831,000 | -26.0% | 9,039 | -29.3% | 0.00% | -20.0% |
| Q2 2015 | $1,123,000 | +15.8% | 12,779 | -8.7% | 0.01% | +25.0% |
| Q1 2014 | $970,000 | +14.9% | 14,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $844,000 | +21.8% | 14,000 | +22.8% | 0.00% | +33.3% |
| Q3 2013 | $693,000 | -54.8% | 11,400 | -50.2% | 0.00% | -57.1% |
| Q2 2013 | $1,532,000 | – | 22,879 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |